The DOI matches its Crossref record; 481 of the 481 references it cites were found in a registry or an index.
Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview
Open accessAbstract
Cancer is a disease caused by the accumulation of genetic and epigenetic changes in two types of genes: tumor suppressor genes (TSGs) and proto-oncogenes. Extensive research has been conducted over the last few decades to elucidate the role of TSGs in cancer development. In cancer, loss of TSG function occurs via the deletion or inactivation of two alleles, according to Knudson’s two-hit model hypothesis. It has become clear that mutations in TSGs are recessive at the level of an individual cell; therefore, a single mutation in a TSG is not sufficient to cause carcinogenesis. However, many studies have identified candidate TSGs that do not conform with this standard definition, including genes inactivated by epigenetic silencing rather than by deletion. In addition, proteasomal degradation by ubiquitination, abnormal cellular localization, and transcriptional regulation are also involved in the inactivation of TSGs. This review incorporates these novel additional mechanisms of TSG inactivation into the existing two-hit model and proposes a revised multiple-hit model that will enable the identification of novel TSGs that can be used as prognostic and predictive biomarkers of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 481
Stelloo, E., Nout, R. A., Naves, L. C. L. M., ter Haar, N. T., Creutzberg, C. L., Smit, V. T. H. B. M., & Bosse, T. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.02.012 · Cited by 96
Faderl, S., Kantarjian, H. M., Estey, E. H., Manshouri, T., Chan, C., Elsaied, A. R., Kornblau, S. M., Cortes, J. E., Thomas, D. A., Pierce, S. A., et al. (2000) · Cancer · doi:10.1002/1097-0142(20001101)89:9<1976::aid-cncr14>3.0.co;2-n · Cited by 95
Fukai, Y., Fukuchi, M., Masuda, N., Osawa, H., Kato, H., Nakajima, T., & Kuwano, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.10929 · Cited by 95
Rahman, N., & Scott, R. H. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm026 · Cited by 95
Alternative splicing and mutation status of CHEK2 in stage III breast cancer
Staalesen, V., Falck, J., Geisler, S. B., Bártková, J., Børresen‐Dale, A., Lukas, J., Lillehaug, J. R., Bártek, J., & Lønning, P. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207928 · Cited by 95
Heterogeneous Methylation and Deletion Patterns of the INK4a/ARF Locus Within Prostate Carcinomas
Konishi, N., Nakamura, M., Kishi, M., Nishimine, M., Ishida, E., & Shimada, K. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62547-3 · Cited by 94
Alterations and hypermethylation of thep14ARF gene in gastric cancer
Iida, S., Akiyama, Y., Nakajima, T., Ichikawa, W., Nihei, Z., Sugihara, K., & Yuasa, Y. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000901)87:5<654::aid-ijc6>3.0.co;2-p · Cited by 93
Ishizaki, Y., Ikeda, S., Fujimori, M., Shimizu, Y., Kurihara, T., Itamoto, T., Kikuchi, A., Okajima, M., & Asahara, T. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.5.1077 · Cited by 93
APC mutations are infrequent but present in human lung cancer
Ohgaki, H. (2003) · Cancer Letters · doi:10.1016/j.canlet.2003.10.020 · Cited by 93
Concomitant inactivation of p53 and Chk2 in breast cancer
Sullivan, A., Yuille, M., Repellin, C., Reddy, A., Reelfs, O., Bell, A., Dunne, B., Gusterson, B. A., Osin, P., Farrell, P. J., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205207 · Cited by 91
Natsugoe, S., Xiangming, C., Matsumoto, M., Okumura, H., Nakashima, S., Sakita, H., Ishigami, S., Baba, M., Takao, S., & Aikou, T. (2002) · PubMed · Cited by 91
Ross, J. S., Ali, S. M., Wang, K., Palmer, G. A., Yelensky, R., Lipson, D., Miller, V. A., Zajchowski, D. A., Shawver, L. K., & Stephens, P. J. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.06.019 · Cited by 90
Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer
Thompson, A., Morris, R., Wallace, M., Wyllie, A. H., Steel, C. M., & Carter, D. C. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.287 · Cited by 90
Molecular Abnormalities Associated with Endocrine Tumors of the Uterine Cervix
Wistuba, I. I., Thomas, B., Behrens, C., Onuki, N., Lindberg, G. M., Albores‐Saavedra, J., & Gazdar, A. F. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1998.5248 · Cited by 90
Regulation of TGF- family signalling by ubiquitination and deubiquitination
Imamura, T., Oshima, Y., & Hikita, A. (2013) · The Journal of Biochemistry · doi:10.1093/jb/mvt097 · Cited by 90
Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma.
Barrett, M. T., Schutte, M. E. M., Kern, S. E., & Reid, B. J. (1996) · PubMed · Cited by 89
E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor
DiFeo, A. V., Narla, G., Camacho‐Vanegas, O., Nishio, H., Rose, S. L., Buller, R. E., Friedman, S. L., Walsh, M. J., & Martignetti, J. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209611 · Cited by 89
Dong, S. M., Kim, K. M., Kim, S. Y., Shin, M. S., Na, E. Y., Lee, S. H., Park, W. S., Yoo, N. J., Jang, J. J., Yoon, C. Y., et al. (1998) · PubMed · Cited by 89
Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer
Barbier‐Torres, L., Delgado, T. C., García‐Rodríguez, J. L., Zubiete‐Franco, I., Fernández‐Ramos, D., Buqué, X., Cano, A., Juan, V. G., Fernández-Domínguez, I., Lopitz‐Otsoa, F., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.3191 · Cited by 88
KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas
Jeng, Y., & Hsu, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11123 · Cited by 88
CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer.
Zhang, P., Wang, J., Gao, W., Yuan, B., Rogers, J., & Reed, E. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-14 · Cited by 88
Lynch, M. A., Nakashima, R., Song, H., DeGroff, V. L., Wang, D., Enomoto, T., & Weghorst, C. M. (1998) · PubMed · Cited by 87
Retinoblastoma gene mutations in primary human bladder cancer
Miyamoto, H., Shuin, T., Torigoe, S., Iwasaki, Y., & Kubota, Y. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.160 · Cited by 87
Rashid, A., Wang, J.-S., Qian, G.-S., Lu, B.-X., Hamilton, S. R., & Groopman, J. D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690321 · Cited by 87
Catto, J. W. F., Xinarianos, G., Burton, J. L., Meuth, M., & Hamdy, F. C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11109 · Cited by 87
Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma
Foulkes, W. D., Black, D. M., Solomon, E., Trowsdale, J., & Stamp, G. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540210 · Cited by 82
Microsatellite instability and mutated type II transforming growth factor-β receptor gene in gliomas
Izumoto, S., Arita, N., Ohnishi, T., Hiraga, S., Taki, T., Tomita, N., Ohue, M., & Hayakawa, T. (1997) · Cancer Letters · doi:10.1016/s0304-3835(96)04583-1 · Cited by 81
Tort, F., Hernandez, S. F., Beà, S., Martı́nez, A., Esteller, M., Herman, J. G., Puig, X., Camacho, E., Sánchez, M., Nayach, I., et al. (2002) · Blood · doi:10.1182/blood-2002-04-1078 · Cited by 81
Zhang, F., White, R. L., & Neufeld, K. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.23.8143-8156.2001 · Cited by 81
Haruki, N., Saito, H., Tatematsu, Y., Konishi, H., Harano, T., Masuda, A., Osada, H., Fujii, Y., & Takahashi, T. (2000) · PubMed · Cited by 80
Microsatellite instability in European hepatocellular carcinoma
Salvucci, M., Lemoine, A., Saffroy, R., Azoulay, D., Lepère, B., Gaillard, S. L., Bismuth, H., REYNES, M., & Debuire, B. (1999) · Oncogene · doi:10.1038/sj.onc.1202279 · Cited by 80
Steinemann, D., Arning, L., Praulich, I., Stuhrmann, M., Hasle, H., Starý, J., Schlegelberger, B., Niemeyer, C. M., & Flotho, C. (2009) · Haematologica · doi:10.3324/haematol.2009.010355 · Cited by 79
Wang, Y., Irish, J. C., MacMillan, C., Brown, D. H., Xuan, Y., Boyington, C., Gullane, P. J., & Kamel‐Reid, S. (2001) · International Journal of Cancer · doi:10.1002/ijc.1337 · Cited by 79
Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma
Arab, K., Smith, L. T., Gast, A., Weichenhan, D., Huang, P.-H., Claus, R., Hielscher, T., Espinosa, A. V., Ringel, M. D., Morris, Q., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr138 · Cited by 79
Aberrant Promoter Methylation of Multiple Genes during Pathogenesis of Bladder Cancer
Brait, M., Begum, S., Carvalho, A. L., Dasgupta, S., Vettore, A. L., Czerniak, B. A., Caballero, O. L., Westra, W. H., Sidransky, D., & Hoque, M. O. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0192 · Cited by 79
Bax, Bcl-2, and p53 Expression in Endometrial Cancer
Sakuragi, N., Salah-Eldin, A.-E., Watari, H., Itoh, T., Inoue, S., Moriuchi, T., & Fujimoto, S. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6742 · Cited by 78
Mutational analysis of TSC1 and TSC2 genes in gangliogliomas
Becker, A. J., Löbach, M., Klein, H., Normann, S., Nöthen, M. M., von Deimling, A., Mizuguchi, M., Elger, C. E., Schramm, J., Wiestler, O. D., et al. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2001.00302.x · Cited by 78
Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer
Karlsson, A., Brunnström, H., Lindquist, K. E., Jirström, K., Jönsson, M., Rosengren, F., Reuterswärd, C., Cirenajwis, H., Borg, Å., Jönsson, P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4314 · Cited by 77
Wang, Z.-J., Churchman, M., Campbell, I., Xu, W.-H., Yan, Z.-Y., McCluggage, W. G., Foulkes, W. D., & Tomlinson, I. P. M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690323 · Cited by 77
Down-regulation of TGF-β receptors in human colorectal cancer: implications for cancer development
Matsushita, M., Matsuzaki, K., Date, M., Watanabe, T., Shibano, K., Nakagawa, T., Yanagitani, S., Amoh, Y., Takemoto, H., Ogata, N., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690339 · Cited by 77
Two sides of the story? Smad4 loss in pancreatic cancer versus head‐and‐neck cancer
Malkoski, S. P., & Wang, X. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.01.054 · Cited by 76
Tanwar, P. S., Mohapatra, G., Chiang, S., Engler, D. A., Zhang, L., Kaneko-Tarui, T., Ohguchi, Y., Birrer, M. J., & Teixeira, J. M. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt357 · Cited by 76
Lücke, C. D., Philpott, A., Metcalfe, J. C., Thompson, A. M., Hughes‐Davies, L., Kemp, P. R., & Hesketh, R. (2001) · PubMed · Cited by 76
Parekh, T. V., Gama, P., Wen, X., Demopoulos, R. I., Munger, J. S., Carcangiu, M. L., Reiß, M., & Gold, L. I. (2002) · PubMed · Cited by 76
Chen, J., Röcken, C., Lofton-Day, C., Schulz, H., Müller, O., Kutzner, N., Malfertheiner, P., & Ebert, M. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh280 · Cited by 75
Differential Roles of p16INK4A and p14ARF Genes in Prognosis of Oral Carcinoma
Sailasree, R., Abhilash, A. J. B., Sathyan, K. M., Nalinakumari, K. R., Thomas, S., & Kannan, S. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0284 · Cited by 75
Comparative Oncogenomics Implicates the Neurofibromin 1 Gene (NF1) as a Breast Cancer Driver
Wallace, M. D., Pfefferle, A. D., Shen, L., McNairn, A. J., Cerami, E. G., Fallon, B. L., Rinaldi, V. D., Southard, T. L., Perou, C. M., & Schimenti, J. C. (2012) · Genetics · doi:10.1534/genetics.112.142802 · Cited by 74
Soufla, G., Sifakis, S., Baritaki, S., Zafiropoulos, A., Koumantakis, E. E., & Spandidos, D. A. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.08.021 · Cited by 74
Association of p53 Gene Mutations with Short Survival in Pancreatic Adenocarcinoma
Nakamori, S., Yashima, K., Murakami, Y., Ishikawa, O., Ohigashi, H., Imaoka, S., Yaegashi, S., Konishi, Y., & Sekiya, T. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb03036.x · Cited by 73
DNA Methylation and Colorectal Cancer
Ashktorab, H., & Brim, H. (2014) · Current Colorectal Cancer Reports · doi:10.1007/s11888-014-0245-2 · Cited by 73
Zhang, H., Chen, X., Wang, M., Wang, J., Qi, Q.-Y., Zhang, R., Xu, W., Fei, Q.-Y., Wang, F., Cheng, Q., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0959-3 · Cited by 72
The Kiss-1/Kiss-1R complex as a negative regulator of cell motility and cancer metastasis (Review)
Ji, K., Ye, L., MASON, M. D., & Jiang, W. G. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1472 · Cited by 71
Chest wall resection in the treatment of locally recurrent breast carcinoma
Faneyte, I. F., Rutgers, E. J. T., & Zoetmulder, F. A. �. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970901)80:5<865::aid-cncr6>3.0.co;2-k · Cited by 70
Busby-Earle, R., Steel, C., Williams, A., Cohen, B. B., & Bird, C. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.138 · Cited by 70
Analysis of PTEN deletions and mutations in multiple myeloma
Chang, H., Xiao, Q., Claudio, J. O., Zhuang, L., Patterson, B. J., & Stewart, A. K. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.07.008 · Cited by 69
Agirre, X., Novo, F. J., Calasanz, M. J., Larráyoz, M. J., Lahortiga, I., Valgañón, M., García‐Delgado, M., & Vizmanos, J. L. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10159 · Cited by 69
BRCA1 and BRCA2 have a limited role in familial prostate cancer.
Sinclair, C. S., Berry, R. M., Schaid, D. J., Thibodeau, S. N., & Couch, F. J. (2000) · PubMed · Cited by 69
Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer
Sato, K., Tamura, G., Tsuchiya, T., Endoh, Y., Usuba, O., Kimura, W., & Motoyama, T. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1888 · Cited by 67
Jiao, W., Datta, J., Lin, H., Dundr, M., & Rane, S. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605271200 · Cited by 67
Molecular Genetics of RB1 ——The Retinoblastoma Gene
Leiderman, Y. I., Kiss, S., & Mukai, S. (2007) · Seminars in Ophthalmology · doi:10.1080/08820530701745165 · Cited by 67
DNA Hypermethylation Status of Multiple Genes in Prostate Adenocarcinomas
Konishi, N., Nakamura, M., Kishi, M., Nishimine, M., Ishida, E., & Shimada, K. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01318.x · Cited by 66
van der Kevie-Kersemaekers, A.-M. F., Hermans, J., Fleuren, G., & van de Vijver, M. J. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.33 · Cited by 66
Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract
Pizzi, S., Azzoni, C., Bassi, D., Bottarelli, L., Milione, M., & Bordi, C. (2003) · Cancer · doi:10.1002/cncr.11621 · Cited by 66
APE1/Ref-1 regulates PTEN expression mediated by Egr-1
Fantini, D., Vascotto, C., Deganuto, M., Bivi, N., Gustincich, S., Marcon, G., Quadrifoglio, F., Damante, G., Bhakat, K. K., MITRA, S. P., et al. (2008) · Free Radical Research · doi:10.1080/10715760701765616 · Cited by 65
Saito, T., Nishimura, M., Yamasaki, H., & Kudo, R. (2003) · Cancer · doi:10.1002/cncr.11157 · Cited by 65
Podszywalow‐Bartnicka, P., Wołczyk, M., Kusio-Kobiałka, M., Wolanin, K., Skowronek, K., Nieborowska-Skorska, M., Dasgupta, Y., Skórski, T., & Piwocka, K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.965013 · Cited by 65
Tumour suppressor genes in prostate cancer
MacGrogan, D., & Bookstein, R. (1997) · Seminars in Cancer Biology · doi:10.1006/scbi.1997.0048 · Cited by 65
DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination
Tarafa, G., Villanueva, A., Farré, L., Rodriguez, J. C., Musulén, E., Reyes, G., Seminago, R., Olmedo, E., Paules, A., Peinado, M. A., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203353 · Cited by 65
Xie, W. Q., Bharathy, S., Kim, D. S., Haffty, B. G., Rimm, D. L., & Reiß, M. (2003) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/000000003108748612 · Cited by 65
Onwuegbusi, B. A., Aitchison, A., Chin, S.-F., Kranjac, T., Mills, I. G., Huang, Y., Lao‐Sirieix, P., Caldas, C., & Fitzgerald, R. C. (2005) · Gut · doi:10.1136/gut.2005.076430 · Cited by 64
Mutation analysis of the CHK2 gene in breast carcinoma and other cancers
Ingvarsson, S., Sigbjornsdottir, B. I., Huiping, C., Hafsteinsdottir, S. H., Ragnarsson, G., Barkardottir, R. B., Arason, A., Egilsson, V., & Bergthorsson, J. T. (2002) · Breast Cancer Research · doi:10.1186/bcr435 · Cited by 63
Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas
Jonson, T., Albrechtsson, E., Axelson, J., et al. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.1.71 · Cited by 63
González‐Gómez, P., Bello, M. J., Alonso, M. E., Arjona, D., Lomas, J. S., de Campos, J. M., Isla, A., & REY, J. A. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600737 · Cited by 63
Loss of heterozygosity: An independent prognostic factor of colorectal cancer
Chang, S. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i6.778 · Cited by 62
CpG methylation of promoter region inactivates E‐cadherin gene in renal cell carcinoma
Nojima, D., Nakajima, K., Li, L.-C., Franks, J., Ribeiro‐Filho, L. A., Ishii, N., & Dahiya, R. (2001) · Molecular Carcinogenesis · doi:10.1002/mc.1060 · Cited by 62
Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer
Aitchison, A., Veerakumarasivam, A., Vias, M., Kumar, R., Hamdy, F. C., Neal, D. E., & Mills, I. G. (2008) · The Prostate · doi:10.1002/pros.20730 · Cited by 62
Functional role of the KLF6 tumour suppressor gene in gastric cancer
Sangodkar, J., Shi, J., DiFeo, A. V., Schwartz, R., Bromberg, R. J., Choudhri, A., McClinch, K., Hatami, R., Scheer, E., Kremer-Tal, S., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.009 · Cited by 61
Hofmann, W., Miller, C. W., Tsukasaki, K., Tavor, S., Ikezoe, T., Hoelzer, D. F., Takeuchi, S., & Koeffler, H. P. (2001) · Leukemia Research · doi:10.1016/s0145-2126(00)00130-2 · Cited by 60
Muro‐Cacho, C., Rosario-Ortiz, K., Livingston, S. K., & Muñoz-Antonia, T. (2001) · PubMed · Cited by 60
Oka, K., Ishikawa, J., Bruner, J. M., Takahashi, R., & Saya, H. (1991) · Molecular Carcinogenesis · doi:10.1002/mc.2940040104 · Cited by 59
Promoter hypermethylation in Indian primary oral squamous cell carcinoma
Kaur, J., Demokan, S., Tripathi, S. C., Macha, M. A., Begum, S., Califano, J. A., & Ralhan, R. (2010) · International Journal of Cancer · doi:10.1002/ijc.25377 · Cited by 59
Genetic and Epigenetic Analysis of CHEK2 in Sporadic Breast, Colon, and Ovarian Cancers
Williams, L. H., Choong, D., Johnson, S. A. S., & Campbell, I. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1770 · Cited by 58
Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer
Tamura, K., Zhang, X., Murakami, Y., Hirohashi, S., Xu, H., Hu, S.-X., Benedict, W. F., & Sekiya, T. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970220)74:1<45::aid-ijc8>3.0.co;2-0 · Cited by 58
Pirh2 RING‐finger E3 ubiquitin ligase: Its role in tumorigenesis and cancer therapy
Jung, Y.-S., Qian, Y., & Chen, X. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.03.052 · Cited by 57
Ling, Z. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.640 · Cited by 57
Xinarianos, G., Liloglou, T., Prime, W., Maloney, P. J., Callaghan, J., Fielding, P., Gosney, J. R., & Field, J. K. (2000) · PubMed · Cited by 56
Jailbreak: Oncogene-induced senescence and its evasion
MDuff, F. K. E., & Turner, S. D. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.07.004 · Cited by 56
Genetic and epigenetic alteration profiles for multiple genes in salivary gland carcinomas
Kishi, M., Nakamura, M., Nishimine, M., Ikuta, M., Kirita, T., & Konishi, N. (2005) · Oral Oncology · doi:10.1016/j.oraloncology.2004.08.004 · Cited by 55
Kafka, A., Tomas, D., Beroš, V., Pećina, H. I., Zeljko, M., & Pećina‐Šlaus, N. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150610635 · Cited by 55
Rosty, C., Walsh, M. D., Lindor, N. M., Thibodeau, S. N., Mundt, E., Gallinger, S., Aronson, M. D., Pollett, A. F., Baron, J. A., Pearson, S., et al. (2014) · Familial Cancer · doi:10.1007/s10689-014-9744-1 · Cited by 55
Díaz-Cano, S. J., Blanes, A., Rubio, J., et al. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780033 · Cited by 55
Netrin-1 overexpression is predictive of ovarian malignancies
Papanastasiou, A. D., Pampalakis, G., Katsaros, D., & Sotiropoulou, G. (2011) · Oncotarget · doi:10.18632/oncotarget.258 · Cited by 55
Tang, J. C. O. (2010) · Oncology Reports · doi:10.3892/or_00000832 · Cited by 55
Bilirubin-induced cell toxicity involves PTEN activation through an APE1/Ref-1-dependent pathway
Cesaratto, L., Calligaris, S. D., Vascotto, C., Deganuto, M., Bellarosa, C., Quadrifoglio, F., Ostrow, J. D., Tiribelli, C., & Tell, G. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0204-3 · Cited by 54
Chetty, R., Serra, S., Salahshor, S., Alsaad, K. O., Shih, W., Blaszyk, H., Woodgett, J. R., & Tsao, M. (2006) · Human Pathology · doi:10.1016/j.humpath.2005.11.002 · Cited by 54
Milea, A. L., George, S. H. L., Matevski, D., Jiang, H., Madunic, M., Berman, H. K., Gauthier, M. L., Gallie, B. L., & Shaw, P. A. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.218 · Cited by 54
Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway
French, D., Belleudi, F., Mauro, M. V., Mazzetta, F., Raffa, S., Fabiano, V., Frega, A., & Torrisi, M. R. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-38 · Cited by 54
Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer
Silva, J., Domínguez, G., Silva, J. M., García, J. M., Gallego, I., Corbacho, C., Provencio, M., España, P., & Bonilla, F. (2001) · Oncogene · doi:10.1038/sj.onc.1204617 · Cited by 54
Jiao, W., Lin, H.-M., Datta, J., Braunschweig, T. A., Chung, J.-Y., Hewitt, S. M., & Rane, S. G. (2007) · Oncogene · doi:10.1038/sj.onc.1210970 · Cited by 53
Galetzka, D., Hansmann, T., Hajj, N. E., Weis, E., Irmscher, B., Ludwig, M., Schneider-Rätzke, B., Kohlschmidt, N., Beyer, V., Bartsch, O., et al. (2012) · Epigenetics · doi:10.4161/epi.7.1.18814 · Cited by 53
Molenaar, J. J., Gérard, B., Pautas, C., Cavé, H., Duval, M., VILMER, E., & Grandchamp, B. (1998) · Blood · doi:10.1182/blood.v92.1.230.413k17_230_233 · Cited by 52
INK4/ARF germline alterations in pancreatic cancer patients
Ghiorzo, P., Pastorino, L., Bonelli, L. A., Cusano, R., Nicora, A., Zupo, S., Queirolo, P., Sertoli, M. R., Pugliese, V., & Bianchi‐Scarrà, G. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg498 · Cited by 52
Tavassoli, M., Steingrimsdottir, H., Pierce, E. A., Jiang, X., Alagöz, M., Farzaneh, F., & Campbell, I. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.324 · Cited by 51
Pinto, M., Oliveíra, C., Cirnes, L., Machado, J. C., RAMIRES, M., Nogueira, A., Carneiro, F., & Seruca, R. (2003) · The Journal of Pathology · doi:10.1002/path.1327 · Cited by 51
BARD1: An independent predictor of survival in non‐small cell lung cancer
Zhang, Y., Bianco, A., Malkinson, A. M., Leoni, V. P., Frau, G., Rosa, N. D., André, P., Versace, R., Boulvain, M., Laurent, G. J., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26346 · Cited by 51
APC promoter methylation and protein expression in hepatocellular carcinoma
Csepregi, A., Röcken, C., Hoffmann, J., Gu, P., Saliger, S., Müller, O., Schneider‐Stock, R., Kutzner, N., Roessner, A., Malfertheiner, P., et al. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0321-y · Cited by 51
Molecular Pathways: Intercellular PTEN and the Potential of PTEN Restoration Therapy
Hopkins, B. D., & Parsons, R. E. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2661 · Cited by 51
Jha, A. K., Nikbakht, M., Jain, V., Sehgal, A., Capalash, N., & Kaur, J. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1787-5 · Cited by 51
Kandioler, D., SCHOPPMANN, S. F., Zwrtek, R., Kappel, S., Wolf, B., Mittlböck, M., Kührer, I., Hejna, M., Pluschnig, U., Ba‐Ssalamah, A., et al. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.06.079 · Cited by 50
Miyamoto, H., Shuin, T., Ikeda, I., Hosaka, M., & Kubota, Y. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)66304-3 · Cited by 50
Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancer
Bártková, J., Guldberg, P., Grønbæk, K., Koed, K., Primdahl, H., Møller, K., Lukas, J., Orntoft, T. F., & Bártek, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207878 · Cited by 49
Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors
Yin, D., Xie, D., Hofmann, W., Miller, C. W., Black, K. L., & Koeffler, H. P. (2002) · Oncogene · doi:10.1038/sj.onc.1206031 · Cited by 49
The Determinants of Head and Neck Cancer: Unmasking the PI3K Pathway Mutations
Squarize, F. S. G. C. H. (2013) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.s5-003 · Cited by 49
Reduced Levels of Transforming Growth Factor‐beta Type I Receptor in Human Gastric Carcinomas
Ito, M., Yasui, W., Nakayama, H., Yokozaki, H., Ito, H., & 田原, 榮. (1992) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1992.tb02356.x · Cited by 48
DCC promoter hypermethylation in esophageal squamous cell carcinoma
Park, H. L., Kim, M. S., Yamashita, K., Westra, W. H., Carvalho, A. L., Lee, J., Jiang, W., Baek, J. H., Liu, J., Osada, M., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23434 · Cited by 48
Zou, Z., Fan, L., Wang, L., Xu, J., Zhang, R., Tian, T., Li, J., & Xu, W. (2014) · Oncotarget · doi:10.18632/oncotarget.2626 · Cited by 47
Self-citationA high-content chemical screen identifies ellipticine as a modulator of p53 nuclear localization
Xu, G. W., Mawji, I. A., Macrae, C. J., Koch, C. A., Datti, A., Wrana, J. L., Dennis, J. W., & Schimmer, A. D. (2008) · APOPTOSIS · doi:10.1007/s10495-007-0175-4 · Cited by 47
NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer
Čaćev, T., Radosević, S., Spaventi, R., Pavelić, K., & Kapitanović, S. (2005) · Gut · doi:10.1136/gut.2004.053348 · Cited by 47
Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer
Murata, H., Khattar, N. H., Gu, L., & Li, G. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.09.039 · Cited by 47
Tumor Suppressor Gene Allelic Loss in Human Renal Cancers
Brooks, J. D., Bova, G. S., Marshall, F. F., & Isaacs, W. B. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35760-9 · Cited by 47
Kloth, J. N., Kenter, G. G., Spijker, H. S., Kolkman-Uljee, S. M., Corver, W. E., Jordanova, E. S., Fleuren, G. J., & Gorter, A. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.62 · Cited by 46
Low frequency of BRAF and CDKN2A mutations in endometrial cancer
Salvesen, H. B., Kumar, R., Stefansson, I. M., Angelini, S., MacDonald, N., Smeds, J., Jacobs, I. J., Hemminki, K., Das, S., & Akslen, L. A. (2005) · International Journal of Cancer · doi:10.1002/ijc.20702 · Cited by 46
p16INK4a and p15INK4b gene promoter methylation in cervical cancer patients
Jha, A. K., Nikbakht, M., JAIN, V., Capalash, N., & Kaur, J. (2012) · Oncology Letters · doi:10.3892/ol.2012.655 · Cited by 46
Wang, J., Zheng, B., Li, X., Nokelainen, K., Ångström, T., Lindström, M. S., & Wallin, K. (2004) · Modern Pathology · doi:10.1038/modpathol.3800308 · Cited by 46
p53 Expression, mutation, and allelic deletion in ovarian cancer
McManus, D. T., Yap, E. P. H., Maxwell, P., Russell, S. E. H., TONER, P. G., & McGee, J. O. (1994) · The Journal of Pathology · doi:10.1002/path.1711740304 · Cited by 46
Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia
Griffiths, E. A., Gore, S. D., Hooker, C. M., Mohammad, H. P., McDevitt, M. A., Smith, B. D., Karp, J. E., Herman, J. G., & Carraway, H. E. (2010) · Epigenetics · doi:10.4161/epi.5.7.12558 · Cited by 46
Tanwar, P. S., Kaneko-Tarui, T., Zhang, L., Tanaka, Y., Crum, C. P., & Teixeira, J. M. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002906 · Cited by 46
Analysis of the TSC1and TSC2genes in sporadic renal cell carcinomas
Parry, L., Maynard, J., Patel, A. S., Clifford, S. C., Morrissey, C. O., Maher, E. R., Cheadle, J. P., & Sampson, J. R. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2072 · Cited by 45
Tanić, N., Milovanovic, Z., Tanic, N., Dzodic, R., Juranic, Z., Susnjar, S., Plesinac-Karapandzic, Tatic, S., Dramićanin, T., Davidovic, R., et al. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.21346 · Cited by 45
Future prospects in prostate cancer
Hegarty, N. J., Fitzpatrick, J. M., Richie, J. P., Scardino, P. T., White, R. D., Schr�der, F. H., & Coffey, D. S. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990901)40:4<225::aid-pros3>3.0.co;2-3 · Cited by 45
Molecular analysis of the retinoblastoma gene in primary ovarian cancer cells
Liu, Y., Hbyman, M., Wang, Y., Falkmer, S., Hising, C., Székely, L., & Einhorn, S. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580508 · Cited by 45
Hartel, M., Narla, G., Wente, M. N., Giese, N. A., Martignoni, M. E., Martignetti, J. A., Friess, H., & Friedman, S. L. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.06.030 · Cited by 45
Bataille, F., Rümmele, P., Dietmaier, W., Gaag, D., Klebl, F., Reichle, A., Wild, P. J., Hofstädter, F., & Hartmann, A. (2003) · Molecular Pathology · doi:10.1136/mp.56.5.286 · Cited by 45
Lin, P.-C., Lin, J.-K., Lin, H., Lan, Y., Lin, C., Yang, S.-H., Chen, W.-S., Liang, W.-Y., Jiang, J., & Chang, S. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0601-y · Cited by 44
Leupin, N., Cenni, B., Novak, U., Hügli, B., Graber, H. U., Tobler, A., & Fey, M. F. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04227.x · Cited by 44
Lin, Y.-C., Diccianni, M. B., Kim, Y., Lin, H.-H., Lee, C.-H., Lin, R.-J., Joo, S. H., Li, J., Chuang, T.-J., Yang, A.-S., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210507 · Cited by 44
RB1 protein in normal and malignant human colorectal tissue and colon cancer cell lines 1
Ali, A. A., Marcus, J. N., Harvey, J. P., Roll, R., Hodgson, C. P., Ck, D. M. W., Chakraborty, A. K., & Roman, B. M. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.10.8344490 · Cited by 43
Bakarakos, P., Theohari, I., Nomikos, A., Mylona, E. E., PAPADIMITRIOU, C. A., Dimopoulos, M. A., & Nakopoulou, L. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03570.x · Cited by 43
Fukasawa, H., Yamamoto, T., Fujigaki, Y., Misaki, T., Ohashi, N., Takayama, T., Suzuki, S., Mugiya, S., Oda, T., Uchida, C., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25164 · Cited by 43
Sobottka, S. B., Haase, M., Fitze, G., Hahn, M., Schackert, H. K., & Schackert, G. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006442024874 · Cited by 42
Aaltonen, V., Boström, P. J., Söderström, K., Hirvonen, O., Tuukkanen, J., Nurmi, M. J., Laato, M. K., & Peltonen, J. T. K. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65322-9 · Cited by 42
Cytoplasmic/Nuclear Shuttling and Tumor Progression
Wang, S., & Hung, M. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1339.002 · Cited by 42
Progesterone Inhibits Endometrial Cancer Invasiveness by Inhibiting the TGFβ Pathway
Bokhari, A. A., Lee, L. R., Raboteau, D., Hamilton, C. A., Maxwell, G. L., Rodriguez, G. C., & Syed, V. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0054 · Cited by 42
Uchida, Τ., Wada, C., Shitara, T., Egawa, S., Mashimo, S., & Koshiba, K. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35764-6 · Cited by 42
Kitajima, Y., Miyazaki, K., Matsukura, S., Tanaka, M., & Sekiguchi, M. (2003) · Gastric Cancer · doi:10.1007/s10120-003-0213-z · Cited by 41
García-Ortí, L., Cristóbal, I., Cirauqui, C., Guruceaga, E., Marcotegui, N., Calasanz, M. J., Castelló-Cros, R., & Odero, M. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047717 · Cited by 41
CpG methylation at promoter site −140 inactivates TGFβ2 receptor gene in prostate cancer
Zhao, H., Shiina, H., Greene, K. L., Li, L.-C., Tanaka, Y., Kishi, H., Igawa, M., Kane, C. J., Carroll, P. R., & Dahiya, R. (2005) · Cancer · doi:10.1002/cncr.21135 · Cited by 41
p53mutations associated with aging-related rise in cancer incidence rates
Richardson, R. B. (2013) · Cell Cycle · doi:10.4161/cc.25494 · Cited by 41
Smad4 deficiency in cervical carcinoma cells
Baldus, S. E., Schwarz, E., Lohrey, C., Zapatka, M., Landsberg, S., Hahn, S. A., Schmidt, D., Dienes, H. P., Schmiegel, W., & Schwarte‐Waldhoff, I. (2004) · Oncogene · doi:10.1038/sj.onc.1208235 · Cited by 40
Parry, L., Maynard, J. H., Patel, A., Hodges, A., von Deimling, A., Sampson, J. R., & Cheadle, J. P. (2000) · Human Genetics · doi:10.1007/s004390000390 · Cited by 39
Inactivation of ELF/TGF-β signaling in human gastrointestinal cancer
Katuri, V., Tang, Y., Marshall, B., Rashid, A., Jogunoori, W. S., Volpe, E. A., Sidawy, A. N., Evans, S. R. T., Blay, J., Gallicano, G. I., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208946 · Cited by 39
Alterations of Chk1 and Chk2 expression in colon cancer
Stawińska, M., Cygankiewicz, A. I., Trzciński, R., Mik, M., Dziki, A. J., & Krajewska, W. M. (2008) · International Journal of Colorectal Disease · doi:10.1007/s00384-008-0551-8 · Cited by 38
Kim, S., Lee, J., Hong, M. E., Do, I., Kang, S. Y., Ha, S. Y., Kim, S. T., Park, S. H., Kang, W. K., Choi, M. G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111693 · Cited by 38
Marrero–Rodríguez, D., Taniguchi‐Ponciano, K., Jiménez-Vega, F., Romero-Morelos, P., Mendoza-Rodríguez, M., Mantilla, A., Rodríguez-Esquivel, M., Hernandez, D., Hernández, Á., Gómez-Gutiérrez, G., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-2380-4 · Cited by 38
Qiu, W., Schönleben, F., Thaker, H. M., Goggins, M., & Su, G. H. (2005) · Oncogene · doi:10.1038/sj.onc.1209325 · Cited by 38
Emerging concepts on the epigenetic and transcriptional regulation of the Kiss1 gene
Semaan, S. J., & Kauffman, A. S. (2013) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2013.03.006 · Cited by 38
Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers
Lièvre, A., Landi, B., Côté, J.-F., Veyrie, N., Zucman‐Rossi, J., Berger, A., & Laurent‐Puig, P. (2005) · Oncogene · doi:10.1038/sj.onc.1208867 · Cited by 38
Gehrau, R. C., D’Astolfo, D. S., Dumur, C. I., Bocco, J. L., & Koritschoner, N. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008929 · Cited by 38
Angus, S. P., Solomon, D. A., Kuschel, L., Hennigan, R. F., & Knudsen, E. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8172-8188.2003 · Cited by 38
Genetic changes of CDH1, APC, and CTNNB1 found in human brain tumors
Nikuševa-Martić, T., Beroš, V., Pećina‐Šlaus, N., Pećina, H. I., & Bulić‐Jakuš, F. (2007) · Pathology - Research and Practice · doi:10.1016/j.prp.2007.07.009 · Cited by 37
Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer
Dunn, J. R., Garde, J., Dolan, K., Gosney, J. R., Sutton, R., Meltzer, S. J., & Field, J. K. (1999) · Oncogene · doi:10.1038/sj.onc.1202371 · Cited by 37
Weber, A., Wittekind, C., & Tannapfel, A. (2003) · Pathology - Research and Practice · doi:10.1078/0344-0338-00435 · Cited by 37
Methylation analysis of the adenomatous polyposis coli (APC) gene in adult T-cell leukemia/lymphoma
Yang, Y., Takeuchi, S., Tsukasaki, K., Yamada, Y., Hata, T., Mori, N., Fukushima, A., Seo, H., Koeffler, H. P., & Taguchi, H. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.05.004 · Cited by 37
Tani, M., Takenoshita, S., Kohno, T., Hagiwara, K., Nagamachi, Y., Harris, C. C., & Yokota, J. (1997) · Carcinogenesis · doi:10.1093/carcin/18.5.1119 · Cited by 37
p53-Induced Apoptosis and Inhibitors of p53
Nayak, S. K., Panesar, P. S., & Kumar, H. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788681976 · Cited by 37
Alterations of tumor suppressor genes and the H‐ras oncogene in oral squamous cell carcinoma
Sakata, K. (1996) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1996.tb00266.x · Cited by 36
Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma
Song, J., Kim, C. J., Cho, Y. G., Kim, S. Y., Nam, S. W., Lee, S. H., Yoo, N. J., Lee, J. Y., & Park, W. S. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04445.x · Cited by 36
Duong, H., Hong, Y. B., Kim, J. S., Lee, H., Yi, Y. W., Kim, Y. J., Wang, A., Zhao, W., Cho, C., Seong, Y., et al. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12101 · Cited by 35
Chiaretti, S., Tavolaro, S., Marinelli, M., Messina, M., Giudice, I. D., Mauro, F. R., Santangelo, S., Piciocchi, A., Peragine, N., Truong, S., et al. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20852 · Cited by 35
Yang, Y., Takeuchi, S., Hofmann, W. K., Ikezoe, T., van Dongen, J. J. M., Szczepański, T., Bartram, C. R., Yoshino, N., Taguchi, H., & Koeffler, H. P. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.06.002 · Cited by 35
Gao, S., Eiberg, H., Krogdahl, A., Liu, C., & Sørensen, J. A. (2005) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2004.00275.x · Cited by 35
Expression of E-Cadherin and uPA and their Association with the Prognosis of Pancreatic Cancer
Shin, S. J., Kim, K. O., Kim, M. K., Lee, K. H., Hyun, M. S., Kim, K., Choi, J. H., & SONG, H. S. (2005) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyi094 · Cited by 35
Polymorphisms and DNA methylation of gene TP53 associated with extra-axial brain tumors
Almeida, L. O., Custódio, A. C., Pinto, G. R., dos Santos, M. J., Almeida, J. R. W., Clara, C., REY, J. A., & Casartelli, C. (2009) · Genetics and Molecular Research · doi:10.4238/vol8-1gmr518 · Cited by 34
Cervical cancer pathogenesis is associated with one-carbon metabolism
Pathak, S., Bhatla, N., & Singh, N. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1362-3 · Cited by 34
Yang, T., Su, Y., Huang, C., Yu, J., Lo, Y., Wu, P., & Shen, C. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20080 · Cited by 34
Down-Regulation of BRCA1 in Chronic Pancreatitis and Sporadic Pancreatic Adenocarcinoma
Beger, C., Ramadani, M., Meyer, S., Leder, G. H., Krüger, M., Welte, K., Gansauge, F., & Beger, H. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0992-3 · Cited by 34
Rooke, H. M., Vitas, M. R., Ps, C., & Crosier, K. (1999) · Leukemia · doi:10.1038/sj.leu.2401384 · Cited by 34
Alteration of the p14 ARF gene and p53 status in human hepatocellular carcinomas
Ito, T., Nishida, N., Fukuda, Y., Nishimura, T., Nakao, K., & Komeda, T. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-003-1302-9 · Cited by 33
Loss of hMLH1 expression correlates with improved survival in stage III–IV ovarian cancer patients
Scartozzi, M., Nictolis, M. D., Galizia, G., Carassai, P., Bianchi, F., Berardi, R., Gesuita, R., Piga, A., Cellerino, R., & Porfiri, E. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00197-7 · Cited by 33
Increased expression of CHK2 in human gastric carcinomas harboring p53 mutations
Shigeishi, H., Yokozaki, H., Oue, N., Kuniyasu, H., Kondo, T., Ishikawa, T., & Yasui, W. (2002) · International Journal of Cancer · doi:10.1002/ijc.10272 · Cited by 33
Absence of KLF6 gene mutation in 71 hepatocellular carcinomas†
Boyault, S., Hérault, A., Balabaud, C. P., & Zucman‐Rossi, J. (2005) · Hepatology · doi:10.1002/hep.20588 · Cited by 33
p53 expression in carcinoma of the cervix.
Hunt, C. R., Hale, R., BUCKLEY, C. H., & Hunt, J. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.12.971 · Cited by 33
Xie, K., He, H., Sun, A., Liu, X.-B., Sun, L. L., & Dong, X.-J. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.6.2591 · Cited by 33
Kim, W. S., Park, C., Hong, S. K., Park, B. K., Kim, H. S., & Park, K. J. (2000) · PubMed · Cited by 32
Somatic alterations of the DPC4 and Madr2 genes in colorectal cancers and relationship to metastasis
Ohtaki, N., Yamaguchi, A., Goi, T., Fukaya, T., Takeuchi, K., Katayama, K., Hirose, K., & Urano, T. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.2.265 · Cited by 32
Zeineldin, M., Cunningham, J., McGuinness, W., Alltizer, P., Cowley, B. C., Blanchat, B., Xu, W., Pinson, D. M., & Neufeld, K. L. (2011) · Oncogene · doi:10.1038/onc.2011.434 · Cited by 32
Maesawa, C., Tamura, G., Nishizuka, S., et al. (1997) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1997.tb00386.x · Cited by 32
Status and Significance of CpG Island Methylator Phenotype in Endometrial Cancer
Zhang, Q., Yi, D., Zhou, L. Q., Zhang, D.-H., & Zhou, T. (2011) · Gynecologic and Obstetric Investigation · doi:10.1159/000324496 · Cited by 32
Different profiles of allelic losses in cervical carcinoma cases in Surinam and the Netherlands
Krul, E. J. T., van der Kevie-Kersemaekers, A.-M. F., Zomerdijk‐Nooyen, Y. A., Cornelisse, C. J., Peters, L. A. W., & Fleuren, G. J. (1999) · Cancer · Cited by 31
Bhagat, R., Kumar, S., Vaderhobli, S., Premalata, C. S., Reddihalli, P. V., Gawari, R., & Krishnamoorthy, L. (2014) · Tumor Biology · doi:10.1007/s13277-014-2136-1 · Cited by 31
Paik, S. Y., Park, Y. N., Kim, H., & Park, C. (2003) · Modern Pathology · doi:10.1097/01.mp.0000047308.03300.9c · Cited by 31
Homozygous deletion of SMAD4 in breast cancer cell lines and invasive ductal carcinomas
Zhong, D., Morikawa, A., Guo, L., Colpaert, C., Xiong, L., Nassar, A., Chen, C., Lamb, N. E., Dong, J., & Zhou, W. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.6.2660 · Cited by 30
Karbova, E., Davidson, B., Metodiev, K., Trope, C. G., & Nesland, J. M. (2002) · International Journal of Surgical Pathology · doi:10.1177/106689690201000302 · Cited by 30
LKB1 Inhibits Breast Cancer Partially through Repressing the Hedgehog Signaling Pathway
Zhuang, Z., Wang, K., Cheng, X., Qu, X., Jiang, B., Li, Z., Luo, J., Shao, Z., & Duan, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067431 · Cited by 30
Niwa, K., Murase, T., Morishita, S., Hashimoto, M., Itoh, N., & Tamaya, T. (1999) · Cancer Detection and Prevention · doi:10.1046/j.1525-1500.1999.09909.x · Cited by 29
Torbenson, M. S., Marinopoulos, S. S., Dang, D. T., Choti, M. A., Ashfaq, R., Maitra, A., Boitnott, J., & Wilentz, R. E. (2002) · Human Pathology · doi:10.1053/hupa.2002.128061 · Cited by 29
Ameri, A., Alidoosti, A., Hosseini, Y., Parvin, M., Emranpour, M. H., Taslimi, F., Salehi, E., & Fadavi, P. (2011) · Chinese Journal of Cancer Research · doi:10.1007/s11670-011-0306-x · Cited by 29
Pathogenetic and biologic significance of TP14ARF alterations in nonsmall cell lung carcinoma
Park, M.-J., Shimizu, K., 中野, 哲., Park, Y. B., Kohno, T., Tani, M., & Yokota, J. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00645-3 · Cited by 29
Uchida, T., Matozaki, T., Suzuki, T., Matsuda, K., Wada, K., Nakano, O., Konda, Y., Nishisaki, H., Nagao, M., Sakamoto, C., et al. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81497-4 · Cited by 29
Patterns of cellular and HPV 16 methylation as biomarkers for cervical neoplasia
Patel, D. A., Rozek, L. S., Colacino, J. A., VanZomeren‐Dohm, A., Ruffin, M. T., Unger, E. R., Dolinoy, D. C., Swan, D. C., Onyekwuluje, J., DeGraffinreid, C. R., et al. (2012) · Journal of Virological Methods · doi:10.1016/j.jviromet.2012.05.022 · Cited by 28
Cited by
Turner, M. C., Andersen, Z. J., Baccarelli, A., Diver, W. R., Gapstur, S. M., Pope, C. A., Prada, D., Samet, J., Thurston, G., & Cohen, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21632 · Cited by 844
Regulating tumor suppressor genes: post-translational modifications
Chen, L., Liu, S., & Tao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0196-9 · Cited by 449
RosettaDDGPrediction for high‐throughput mutational scans: From stability to binding
(2022) · doi:10.1002/pro.4527 · Cited by 90
Ansari, M. A., Thiruvengadam, M., Venkidasamy, B., Alomary, M. N., Salawi, A., Chung, I.-M., Shariati, M. A., & Rebezov, M. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.04.005 · Cited by 63
Zhong, G., Zhao, Y., Zhuang, D., Chung, W. K., & Shen, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-62318-4 · Cited by 15
Metadata
- Authors
- Wang, L.-H., Wu, C.-F., Rajasekaran, N., & Shin, Y. K.
- Venue
- Cellular Physiology and Biochemistry
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 51
- Issue
- 6
- Pages
- 2647-2693
- ISSN
- 1015-8987 (ISSN-L)
- 1421-9778
- OpenAlex
- W2903826068
- Cited by
- 334
- References
- 481
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.